Table 1.
Clinical and demographic data of study group subjects (n = 14).
| G− (n = 5) | G+ (n = 9) | |
|---|---|---|
| Female gender, n (%) | 2 (40%) | 5 (56%) |
| Median age (min–max) | 57 (34–66) | 38 (23–57) |
| Duration of hearing loss (years): median (min–max) | 18.8 (1–36) | 12.8 (1–43) |
| Cochlear implant activation (months): median (min–max) | 20.33 (5–55) | 25 (9–37) |
| Nucleus 22 processing strategy: speak | 3 | 2 |
| Nucleus 24 processing strategy: ACE | 2 | 7 |
| Deafness etiology | ||
| Meningitis | 5 | 0 |
| Trauma | 0 | 1 |
| Otosclerosis | 0 | 2 |
| Ototoxicity | 0 | 1 |
| Chronic otitis media | 0 | 1 |
| Unknown | 0 | 4 |
G−, cochlear implant users with poor hearing performance; G+, cochlear implant users with good hearing performance; min–max, minimum–maximum; ACE, advanced combination encoder.